EliteCell

EliteCell is a biotechnology company specializing in regenerative medicine and the development of advanced cell culture solutions. The company is a leader in the production of high-quality, animal-serum-free culture media and supplements, most notably its human platelet lysate (hPL) products designed for the expansion of mesenchymal stem cells (MSCs). EliteCell also maintains an active clinical pipeline, developing MSC-based therapies for indications such as osteoarthritis, critical limb ischemia, and chronic wounds. With operations in both Taiwan and the United States, the company provides GMP-compliant tools and therapeutic candidates to the global life sciences market. EliteCell's mission is to standardize and optimize cell therapy production to improve patient outcomes in regenerative medicine.